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Epigenetic gene silencing is one of the fundamental mechanisms for ensuring proper gene expression patterns during cellular
diﬀerentiation and development. Histone deacetylases (HDACs) are evolutionally conserved enzymes that remove acetyl
modiﬁcations from histones and play a central role in epigenetic gene silencing. In cells, HDAC forms a multiprotein complex
(HDAC complex) in which the associated proteins are believed to help HDAC carry out its cellular functions. Though each HDAC
complex contains distinct components, the presence of isoforms for some of the components expands the variety of complexes
and the diversity of their cellular roles. Recent studies have also revealed a functional link between HDAC complexes and speciﬁc
histone demethylases. In this paper, we summarize the distinct and cooperative roles of four class I HDAC complexes, Sin3, NuRD,
CoREST, and NCoR/SMRT, with respect to their component diversity and their relationship with speciﬁc histone demethylases.
1.Introduction
Eukaryoticchromosomesconsistoftwocytologicallydeﬁned
structures,euchromatin,andheterochromatin.Euchromatin
contains transcribable genes, which are subject to either
activationorinactivationdependingonthecellularsituation,
whereas heterochromatin contains transcriptionally inert
genes. Structural changes in chromatin are tightly linked
with posttranscriptional modiﬁcations of the histone tails.
The combinations of histone modiﬁcations establish local
and global patterns of chromatin structure and deﬁne
speciﬁc downstream events [1]. These patterns are highly
dynamic and can be altered by multiple extracellular and
intracellular stimuli. Thus, chromatin has been proposed
to serve as a signaling platform by which various signaling
pathways are integrated.
Among the numerous covalent modiﬁcations identiﬁed
so far, acetylation and methylation play central roles in
chromatin dynamics [2]. Histone acetylation on lysine
residues is primarily associated with gene activation, and
its levels are controlled by two counteracting enzymes:
histone acetyltransferases (HATs) and histone deacetylases
(HDACs). Many lysine and arginine residues on histones
are target sites of methylation. In contrast to acetylation,
histone methylation is linked with both gene activation and
inactivation and is regulated by histone methyltransferases
(HMTs) and histone demethylases (HDMs). In most cases,
these histone-modifying enzymes are present in multisub-
unit protein complexes, in which the other components are
thought to regulate enzyme activities, modulate substrate
recognition, recruit other cofactors, or carry out other
undeﬁned functions.
In metazoans, HDACs are divided into three classes,
Class I to Class III, based on their sequence similarity. Class
I HDACs, which include HDAC1, HDAC2, and HDAC3,
are found in four distinct multiprotein complexes, the
Sin3, NuRD, CoREST, and NCoR/SMRT complexes. These
complexes are highly conserved and function in distinct
cellular processes including cell-cycle regulation [3, 4],
maintenance of stem cell pluripotency [5], self-renewal, and
cellular diﬀerentiation. Recent studies have revealed that
all of these complexes are associated with speciﬁc HDMs.
The HDMs are classiﬁed into two distinct enzyme families:
the nuclear amine oxidase homologs and the JmjC-domain2 Journal of Biomedicine and Biotechnology
Sin3 core complex
HDAC1
HDAC2
RbAp46
RbAp48
RBP2
Sin3A Sin3B or
SAP30
SAP18
Pf1
EMSY
Sin3-RBP2 complex
MRG15
Mammals
(a)
Rpd3 Ume1
Sin3
Rco1
Eaf3
Rpd3S complex
S. cerevisiae
(b)
RPD3
NAP1
RLAF-N complex
Drosophila
LID LID
Sin3A Sin3A
PF1 PF1
EMSY EMSY
MRG15 MRG15
ASF1
LAF-A complex
(c)
Figure 1: The Sin3 complexes. Schematic representation of the Sin3-containing HDAC complexes: (a) the Sin3-core and Sin3-RBP2
complexes in mammalian cells; (b) the Rpd3S complex in S. cerevisiae; (c) RLAF-N and LAF-A complexes in Drosophila. The empty dotted
boxes indicate missing subunits compared with the Sin3-core complex.
proteins. LSD1 (KDM1A, also known as AOF2/BHC110) is
a member of the former family and was the ﬁrst histone
lysine demethylase identiﬁed; it preferentially demethylates
methylated histone H3 lysine 4 (H3K4me) [6]. The latter
enzyme family, the JmjC-domain proteins, plays important
rolesindevelopmentandcellulardiﬀerentiation[7–10].This
family has 27 members in mammals, and these members
are divided into 11 subgroups based on similarity within the
JmjCdomain[11].Sofar,sevenofthesesubgroupshavebeen
shown to have demethylase activity for speciﬁc residues on
histone H3 or H4.
To achieve strict transcriptional regulation in the comp-
licated chromosomal architecture of the nucleus, it makes
sense that eukaryotic organisms developed a system involv-
ing combinatorial histone modiﬁcations and protein com-
plexes that contain multiple enzymatic activities, such as
HDAC and HDM. It is noteworthy that cells produce a
variety of HDAC-containing complexes by replacing an
integral component with one of its subtypes. These sub-
type-speciﬁc HDAC complexes appear to play distinct roles
in particular cellular contexts. In addition, incorporating
sequence-speciﬁc DNA-binding proteins, such as zinc-ﬁnger
proteins, can also modulate the function of the HDAC
complex. In this paper, we focus on how HDAC-HDM
interactions and subtype-speciﬁcity regulate functions of
the Class I HDAC-containing complexes, in transcriptional
regulation and other cellular processes.
2. The Sin3 Complex
The HDAC-containing multiprotein complex, Sin3 complex,
is highly conserved from yeast to humans. In mammalian
cells, the Sin3 complex consists of six core subunits,
HDAC1/2, RbAp46, RbAp48, Sin3A/Sin3B, SAP18, and
SAP30 (Figure 1(a))[ 12–14]. Mammalian Sin3A and Sin3B
(mSin3A and mSin3B) show high sequence similarity and
an overlapping expression pattern, and both are essential in
mouse development. However, these subtypes play distinct
and nonoverlapping roles. mSin3A has a critical role in
the early developmental preimplantation stage, since no
mSin3A-null zygotes are found at E6.5 [15]. mSin3A-
depleted mouse embryonic ﬁbroblasts (MEFs) exhibit the
deregulation of genes involved in cell-cycle control, DNA
replication, DNA repair, apoptosis, chromatin modiﬁcation,
and mitochondrial metabolism. Transcriptome analysis has
revealed that mSin3A modulates the transcriptional network
controlled by Myc-Mad, E2F, or p53. On the other hand,
mSin3B has an essential function at the late-gestation stage,
and its mutant is diﬀerent from the mSin3A-/- embryo [16].
In particular, erythrocyte and granulocyte diﬀerentiation
and G0/G1 cell-cycle control are impaired in the mSin3B-/-
embryo, and these phenotypes are due to the derepression of
E 2 Ft a r g e tg e n e s .
Transcriptional regulation is tightly coupled with dyn-
amic change of histone acetylation in the promoter regions.
However, the Sin3 complex functions not only at promoter
regions but also at transcribed regions. In Saccharomyces
cerevisiae, Sin3 and a Class I HDAC, Rpd3, are involved
with two functionally distinct complexes, Rpd3L and Rpd3S
[17]. Both complexes contain Sin3, Rpd3, and Ume1. In
addition to these core subunits, Rpd3L contains at least six
unique components: Rxt1, Rxt2, Dep1, Sds3, Pho23, and
Sap30, whereas Rpd3S contains Rco1 and Eaf3 as unique
components (Figure 1(b))[ 18]. Rpd3L is localized primarily
to promoter regions. In contrast, Rpd3S is localized to
transcribed regions that are enriched in methylated H3K36
(H3K36me). H3K36me is a mark catalyzed by Set2 (KMT3)
and is tightly coupled with the transcriptional elongation
processes [19]. Rpd3S recognizes this H3K36me mark viaJournal of Biomedicine and Biotechnology 3
a combined action of chromodomain of Eaf3 and PHD
(plant homeobox domain) of Rco1 [20–22]. Deletion of Set2
or one of the Rpd3S-speciﬁc components results in spurious
transcripts that emerge from incorrect transcription start
sites in some transcriptionally active genes [17]. Since the
H4acetylationlevelswithintranscribedregionsareincreased
in these mutant cells, Rpd3S is thought to repress unfavor-
able transcription by maintaining transcribed regions in a
hypoacetylatedstate.Inmetazoans,however,therelationship
between mSin3 complexes and the emergence of aberrant
transcripts remains unclear.
One of the Rpd3S-speciﬁc components, Eaf3, is highly
conserved from yeast to humans. The human Eaf3 homo-
logue MRG15 was initially identiﬁed as a factor closely
related to MORF4 (mortality factor on human chromosome
4), whose transient expression induces senescence in a sub-
set of human tumor cell lines [23, 24]. MRG15 is
a stable component of mSin3-HDAC complexes, and the
MRG15-associated mSin3-HDAC complex also contains
Pf1, a component that shares similarity with S. cerevisiae
Rco1 [25], and a histone H3K4-speciﬁc demethylase, RBP2
(KDM5A) [26] (Figure 1(a)). Of note, MRG15 is shared
with at least two other complexes: the Tip60 (NuA4)-HAT
complex [26–28] and the BRCA2-containing DNA-damage-
responsive complexes [29, 30]. Although we will not discuss
these complexes further in this paper, the MRG15-associated
complexes are implicated in DNA-damage responses [29,
31–33], in addition to transcriptional regulation, sug-
gesting that histone acetylation dynamics is tightly cou-
pled with histone eviction/deposition during DNA-repair
processes.
We previously demonstrated that MRG15 recruits RBP2
and controls the H3K4me levels on transcribed regions
via the RBP2 activity [26]. In addition, van Oevelen et al.
reported that the majority of Sin3 target genes (58%) are
bound by RBP2, which spreads over the region immediately
downstream of the transcription start site on a subset of
E2F target genes during diﬀerentiation [34]. These results
suggest that the Sin3-HDAC complex and RBP2 play a
cooperative role in repressing target genes through deacety-
lation, demethylation, and, probably, the repositioning of
nucleosomes. In S. cerevisiae,n oe v i d e n c eh a sb e e nr e p o r t e d
for a physical interaction or functional link between the Sin3
complex and the KDM5 homologue Jhd2. In Drosophila,
RPD3, MRG15, and PF1, but not SIN3, were identiﬁed in
an LID-(a KDM5 homologue) containing complex [35].
Intriguingly, the deacetylation activity of RPD3 is inhibited
by its interaction with any of these associated proteins,
including LID, implying that the relationship between the
HDAC and HDM activities is counteractive.
Recent reports have shown that LID associates with SIN3
and functions in Notch silencing [36]. The Notch signaling
pathway plays pleiotropic roles during embryonic develop-
ment and is important for the regulation of cellular self-
renewal [37, 38]. Moshkin et al., puriﬁed factors associated
with histone chaperones (ASF1 and NAP1) from Drosophila
S2 cells or embryonic nuclear extract, and identiﬁed sev-
eral peptides, including LID, SIN3A, PF1, RPD3, MRG15,
and a BRCA2-binding protein, EMSY. Using a reciprocal
puriﬁcation approach, they further showed that NAP1 binds
the RPD3 and LID-Associated Factors (RLAFs) consisting of
RPD3, LID, SIN3A, PF1, EMSY, and MRG15, whereas ASF1
binds LAF, a similar complex lacking RPD3 (Figure 1(c)).
Both of these complexes, RLAF-NAP1 (RLAF-N) and LAF-
ASF1(LAF-A),arerequiredforthetranscriptionalrepression
of Notch-regulated genes. In agreement with the enzymatic
activity of LID, the knockdown of ASF1, NAP1, or any of the
LAF components results in an accumulation of H3K4me3 at
the promoter and enhancer regions. Interestingly, H3K4me3
accumulationisnotobservedinRPD3knockdowncells[36].
This implies that LID recruitment to the promoter/enhancer
regions of Notch target genes may not depend on the
entire RPD3-containing RLAF complex. Considering that
the RPD3-containing RLAF complex resembles Rpd3S in S.
cerevisiae in its subunit composition (Figures 1(b) and 1(c)),
it is possible that RLAF acts at the rest of transcribed regions,
with or without the association with NAP1. This possibility
will be tested by future studies.
RBP2/KDM5A was also found to be involved in the
Notch pathway in a study using mammalian cells [39]. RBP-J
isa nuclear eﬀectorof Notchsignaling. Upon ligandbinding,
RBP-J activates the expression of Notch target genes, and,
in the absence of Notch signal, RBP-J switches oﬀ the target
gene expression. Liefke et al. showed that RBP2/KDM5A
associates with RBP-J in vivo. RBP2/KDM5A is colocalized
with RBP-J at the promoter region of Notch target genes
and regulates their expression. Although the involvement of
HDAC at the target promoter region was not described in
this study, it is most likely that RBP2 works together with
an HDAC complex, as in the case of the LAF-A complex in
Drosophila.
Another function of the Sin3 complex was revealed
by a genome-wide study. The gene-expression proﬁles of
Sin3-depleted Drosophila cells were analyzed by high-density
oligonucleotide array [40]. This analysis revealed that the
expression of ∼3% of the Drosophila genes is altered in
Sin3-depleted cells. The aﬀected genes are associated with
diverse biological processes, including signal transduction,
transcriptional regulation, and cell-cycle control. Interest-
ingly, the list of aﬀected genes also includes a substantial
fraction of genes involved in cytosolic and mitochondrial
energy-generating pathways. Furthermore, Sin3-deﬁcient
Drosophilacellsexhibitanincreaseinmitochondrialmass.In
accordance with this observation, the genome-wide analysis
of RBP2-binding sites using human breast cancer cell lines
revealed that RBP2 is enriched at genes encoding proteins
that localize to the mitochondrion, including mitochondrial
ribosomal proteins [41]. Moreover, the alteration of RBP2
leads to mitochondrial defects in human cells, as in Sin3-
depleted Drosophila cells.
Overall, the Sin3-HDAC complexes associated with
KDM5 regulate the transcription of many genes, in pro-
cesses such as Notch signaling and mitochondrial func-
tions. Notably, the transcriptional regulation is achieved
by dynamic changes in histone modiﬁcations not only at
promoter regions, but also at transcribed regions. The Sin3-
KDM5 complex appears to play an important role at both
regions by exchanging its associated cofactors.4 Journal of Biomedicine and Biotechnology
3. The Mi-2/NuRD Complex
The NuRD complex was ﬁrst puriﬁed based on its histone
deacetylase and nucleosome-remodeling activities [14, 42,
43]. Although the NuRD complex has been identiﬁed in
mammalian and Xenopus cells, its major components have
also been found in Drosophila, C. elegans,a n dArabidopsis,
suggesting that the complex exists widely in animal and
plant species. The biochemical association of the histone
deacetylase and nucleosome-remodeling activities suggests
that these two activities are functionally coupled in this
complex action.
The NuRD core complex consists of HDAC1/2, RbAp46,
RbAp48, CHD3/CHD4 (Mi-2), MBD2/MBD3, MTA1/
MTA2/MTA3, and p66α/p66β (Figure 2(a)). HDAC1/2 and
RbAp46/48 are shared with the Sin3 complex. Mi-2 was
ﬁrst identiﬁed as an autoantigen in the human connective
tissue disease dermatomyositis [44], and is a member of the
SWI2/SNF2-related chromatin-remodeling ATPases, which
target the chromatin region and unwind the nucleosome
structure. MBD2 and MBD3 belong to the MBD (methyl-
CpG binding) domain family although MBD3 is unable to
bind methyl-CpG [45, 46]. Since the NuRD complex can
interact with both MBD2 and MBD3, it was ﬁrst hypoth-
esized to target methylated DNA through its interaction
with MBD2 [47]. However, recent reports have shown that
MBD3 and MBD2 are exclusively associated with the NuRD
complex and form distinct complexes, MBD3/NuRD and
MBD2/NuRD [48]. MBD3 and MBD2 are very similar
(70% identical), but only MBD3 is essential for mouse
development [49].
The MTA protein family has three members, MTA1,
MTA2, and MTA3, and vertebrates have two additional
splicing variants, small form of MTA1 (MTA1s) and MTA3L
[50,51]. MTA1s,however,lacksanuclearlocalizationsignal
and is found in the cytoplasm [50]; it is therefore unlikely to
beacomponentofnuclearMi-2/NuRD.AmongtheseMTAs,
MTA1 and MTA3 have been clearly shown to be involved
in tumor progression. Their expression is upregulated in
several types of tumors, and their expression states are
closely correlated with the invasive growth properties of
tumors [51–53]. MTA1 is induced by the growth factor
heregulin and is a potent corepressor of estrogen-receptor
element-(ERE-)driven transcription [54]. Similarly, in breast
epithelial cells, MTA3 is induced by estrogen, constitutes an
estrogen-dependentcomponentoftheMi-2/NuRDcomplex,
and plays a critical role in repressing the expression of
Snail, a master regulator of the epithelial-to-mesenchymal
transition [51]. These data suggest that MTA proteins are
mutually exclusive in the NuRD complex (Figure 2(a))a n d
that distinct NuRD complexes function as transcriptional
repressors in diﬀerent signaling pathways.
T h eN u R Dc o m p l e xp l a y si m p o r t a n tr o l e si nd e v e l o p -
ment. Mice lacking a functional Mbd3 gene die prior to
midgestation [49]. Embryonic stem (ES) cells lacking Mbd3
are viable, but they fail to completely silence genes that are
expressed before implantation of the embryo [55]a n da r e
unable to commit to developmental lineages [56]. Another
NuRD component, p66, was ﬁrst cloned in Drosophila as
a genetic modiﬁer of the Wingless signaling pathway. The
human paralogs p66α (GATAD2A) and p66β (GATAD2B)
function synergistically in transcriptional repression, and
both bind to MBD2 [57]. Although p66α is not required
for normal blastocyst development or implantation, loss-of-
function mutant embryos of p66α die at around day 10 of
embryogenesis [58].
ES cells require several key molecules, such as Nanog and
Oct4, for their self-renewal and pluripotency [59]. Nanog-
containing complexes were recently puriﬁed from mouse ES
cells, and several NuRD-related components were identiﬁed
as Nanog-interacting proteins [5]. Interestingly, the Nanog-
interacting NuRD-like complex contains most of the NuRD
components (Mta1, Mta2, Hdac1/2, p66α, and p66β)b u t
lacks Chd3/4, Mbd3, and RbAp46/Rbbp7 (Figure 2(b)). This
NuRD-like unique complex was thus named NODE (for
Nanog- and Oct4-associated deacetylase). Without Mbd3,
deacetylase activity in the canonical NuRD complex is
greatly reduced [47], but the NODE complex contains
HDAC activity comparable to that of NuRD complexes.
Importantly,Mbd3-knockdownEScellsshowdiﬀerentgene-
expression proﬁles than Mta1- or Mta2-knockdown ES cells.
Moreover, while Mbd3 loss-of-function mutant ES cells can
self-renew, the knockdown of NODE subunits leads to the
increased expression of developmentally regulated genes and
ES-cell diﬀerentiation. These observations support the idea
that NODE is functionally distinct from canonical NuRD.
Although the functional interaction between NuRD/
NODE and histone demethylases in ES cells is still unknown,
cooperative roles of NuRD and LSD1 have been described
(Figure 2(a))[ 60]. Using HeLa cells, Wang et al. puriﬁed the
MTA2-containing protein complexes and identiﬁed LSD1 in
addition to other NuRD components [60]. LSD1 interacts
directly with all three MTA proteins and appears to form
distinct complexes. The NuRD-LSD1 complexes target dis-
tinct, yet overlapping, sets of genes. Transcriptional analyses
have revealed that these complexes regulate several cellular
signaling pathways, including TGFβ, cell-communication,
focal-adhesion, MAPK, and cell-cycle pathways, which are
critically involved in cell growth, survival, migration, and
invasion. Furthermore, LSD1 inhibits the invasion of breast
cancer cells in a Mi-2-dependent manner in vitro and
suppresses breast cancer metastatic potential in vivo.I nf a c t ,
LSD1 is downregulated in breast carcinomas and negatively
correlated with TGFβ1 expression.
Collectively, the LSD1/NuRD complex is required for the
repression of important genes in cellular signaling pathways
and suppresses breast cancer metastasis. While LSD1 is a
component of NuRD complexes, it has been also observed
that LSD1 targets promoter regions independent of NuRD
[60]. Therefore, it is likely that LSD1 also functions as a
component of currently unidentiﬁed protein complexes.
4. The CoRESTComplex
CoREST was ﬁrst identiﬁed as a corepressor of REST (RE-
1 Silencing Transcription Factor, also known as NRSF)
[61] and later demonstrated to be a component ofJournal of Biomedicine and Biotechnology 5
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Figure 2: The NuRD complexes. Schematic representation of the NuRD complex (a) and ES cell-speciﬁc NODE complex (b). The empty
dotted boxes indicate missing subunits compared with the NuRD complex.
HDAC1/2-containingcomplexes[62].TheCoRESTcomplex
contains HDAC1/2, p80, Sox-like protein, ZNF217 (p110a),
and LSD1 (p110b) (Figure 3(a)). Although p110b was
identiﬁed in the ﬁrst puriﬁcation study, its catalytic activity
was later identiﬁed and renamed LSD1 [6]. Because the
CoREST complex does not associate with mSin3, MTA,
CHD4, or RbAp46/48, it is thought to be distinct from
the other HDAC-containing complexes. The CoREST pro-
tein contains two SANT domains, a conserved domain
resembling the DNA-binding domains of Myb-related DNA-
binding proteins. This domain was originally identiﬁed in
SWI3, ADA3, NCoR, and TFIIIB (and thus named SANT)
[63], and it is also present in the MTA proteins. Interest-
ingly, the demethylase activity of LSD1 to the nucleosomal
substrates requires the CoREST protein [64]. In addition,
the CoREST/LSD1 complex shows high demethylase activity
for a hypoacetylated nucleosome substrate, and the SANT
domain of CoREST preferentially interacts with hypoacety-
lated histone tails, as was also previously observed for the
SANT domain of SMRT [65]. These results suggest that the
HDACs in the CoREST/LSD1 complex function upstream of
LSD1 and that deacetylated states are recognized by CoREST,
which facilitates LSD1’s enzymatic activity.
ZNF217, the other CoREST complex component, is
aK r ¨ uppel-like zinc-ﬁnger protein. The ZNF217 complex
puriﬁed from HeLa cells includes LSD1, CoREST, HDAC2,
and CtBP [66]. The zinc-ﬁnger motif of ZNF217 speciﬁcally
binds to the DNA sequence CAGAAY (Y means C or T),
and this consensus is highly conserved in the E-cadherin
promoter. In fact, ZNF217 and other CoREST complex
components are found on the E-cadherin promoter, which
is repressed by ZNF217. As ZNF217 overexpression has been
noted in many cancer cell lines [66], aberrant protein levels
of ZNF217 may cause unregulated targeting by the CoREST-
LSD1complex,withaprofoundeﬀectoncancerprogression.
The transcriptional corepressor CtBP (C-terminal
binding protein) is also implicated in tumorigenesis.
Immunoaﬃnity puriﬁcation of the CtBP complex revealed
that it contains all of the CoREST complex components [67].
In this analysis, many other interactors were also identiﬁed
(G9a, HuHMT, HPC2, REBB-1, and ZNF516) [67]. As
described for ZNF217, CtBP and the complex components,
EuHMT and G9a, also repress E-cadherin promoter activity.
Another report showed that Snail, a master regulator of
the epithelial-to-mesenchymal transition, forms a complex
with LSD1 and CoREST, and functions to recruit LSD1
activity to the E-cadherin promoter [68]. Together, these
results suggest that the CoREST complex is a kind of
“core complex” that associates with the CtBP complex
as an eﬀector module (Figure 3(a)). Considering that
CoREST also associates with other corepressors required
for hematopoietic diﬀerentiation, Gﬁ-1 and Gﬁ1-b [69],
it is likely that CoREST forms several distinct complexes
depending on the cellular situation.
5. The NCoR/SMRT Complex
Nuclear hormone receptors are evolutionally conserved,
ligand-dependent transcription factors that inﬂuence the
biological processes of cell proliferation and diﬀerentiation
in metazoans. NCoR (Nuclear receptor CoRepressor, also
known as NCOR1) and SMRT (Silencing Mediator for
Retinoid and Thyroid receptor, also known as NCOR2) bind
to nuclear hormone receptors and act as “platform proteins”
inrecruitingalargeproteincomplexthatincludesClassIand
II HDAC and mSin3A [70]. Of note, proteins homologous
to NCoR or SMRT are not found in the yeast genome, as is
the case for the nuclear hormone receptors. These proteins
appear to have arisen during the evolution of metazoan
organisms to allow unliganded nuclear hormone receptors6 Journal of Biomedicine and Biotechnology
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Figure 3: The CoREST and NCoR/SMRT complexes. Schematic representation of the CoREST (a) and the NCoR/SMRT (b) complexes. The
CoREST complex is included in the CtBP-containing complexes. The empty dotted boxes indicate that both CoREST and NCoR/SMRT
complexes lack RbAp46/RbAp48 subunits, which are widely observed in HDAC-containing complexes.
to repress transcription via the Sin3-HDAC pathway [70].
SMRT and NCoR share a similar domain organization and
are thought to be paralogues.
NCoRandSMRTareessentialfordevelopment,buttheir
mutant phenotypes are quite diﬀerent. NCoR appears to
be critical to neural diﬀerentiation and the developmen-
tal progression of erythrocytes and thymocytes [71, 72],
whereas SMRT is required for heart development [72]. The
SMRT and NCoR complexes share interacting partners,
including HDAC3, TBL1 (transducin β-like 1), TBLR1 (TBL
related 1), and GPS2 (G-protein pathway suppressor 2)
(Figure 3(b))( r e v i e w e di n[ 73]). Moreover, 114 and 98
proteins, respectively, are reported to interact physically
with NcoR and SMRT (BioGRID). NCoR and SMRT also
associate with other HDAC members, HDAC4, HDAC5, and
HDAC7, but these enzymatic activities are dependent on
the SMRT/NCoR-HDAC3 complex [74]. Previous studies
demonstrated that diverse transcription factors, including
Mad/Mxi, BCL6/LAZ3, ETO, RBP-J, and REST/NRSF, inter-
act with the NCoR and SMRT complexes [75, 76].
Several demethylases that interact with NCoR
have been identiﬁed. KDM4A (former name, JMJD2/
JDM3A/JMJD2A/KIAA0677) was identiﬁed in an aﬃnity-
p u r i ﬁ e dN C o Rc o m p l e x[ 77]. KDM4A is not a core
subunit of the NCoR complex, and it is not required for
NCoR-mediated repression by thyroid hormone receptor.
However, KDM4A is required for selective repression of
the ASCL2 gene, which is an imprinted gene essential for
proper placental development, and this repression requires
a functional NCoR complex [78]. KDM4A speciﬁcally
demethylates tri- and dimethylated lysine-9 and lysine-36
of histone H3 (H3K9/36 me3/2) [79]. A recent study
showed that KDM4 also demethylates lysine-26 of histone
H1.4 (H1.4K26me), which is one of seven somatic H1
isotypes in humans, and is known to cause transcriptional
repression [80]. Considering that both H3K9me3/2 and
H1.4K26me are repressive histone marks, it is unclear how
KDM4’s enzymatic activity is coupled with NCoR-mediated
repression. Nevertheless, the substrate speciﬁcity of KDM4
may be modulated within N-CoR-containing complexes.
Further studies are required to elucidate the function of
the KDM4-associated NCoR complex and the resulting
histone-modiﬁcation dynamics.
KDM5C (also known as SMCX/JARID1C) has histone
H3K4-speciﬁc demethylase activity and functions as a
transcriptional repressor. KDM5C is implicated in X-linked
mental retardation, epilepsy, and autism [81–83]. Tahiliani
et al., puriﬁed a KDM5C-containing complex from HeLa
cells and identiﬁed NCoR [84]. This complex also contains
HDAC1/2, the H3K9-speciﬁc methyltransferase G9a, REST
(RE-1 Silencing Transcription factor, also known as NRSF),
which represses neuronal genes in non-neuronal tissues,
along with other proteins that are primarily involved in
transcriptional repression. REST not only maintains the
transcriptional silencing of a range of neuronal genes in
diﬀerentiated non-neuronal cells but also plays key roles
during lineage commitment in neurogenesis (reviewed in
[85]). Tahiliani et al., further showed that KDM5C functions
at a subset of REST-regulated neuronal speciﬁc genes [84].
It should be noted that NCoR was previously shown to
form a stable complex with HDAC3, TBL1, TBLR1, and
GPS2 [73], but these proteins were not identiﬁed in the
KDM5C-containing complex. Thus, it is not clear how
NCoR functions in the KDM5C-REST complex. However, a
requirement for NCoR in astroglia diﬀerentiation was clearly
demonstrated [71]. REST modulates not only neuronal, but
also glial lineage elaboration [86]. Therefore, it is possible
that a unique NCoR-SMCX-REST complex speciﬁcallyfunc-
tions in glial development.
Despite its similarity to the NCoR complex, there is no
report showing a direct interaction between the SMRT com-
plex and HDMs. However, SMRT appears to control HDM
function in trans. SMRT knockout mice exhibit embryonic
lethality, with impaired neural development as well as heart
defects [72]. SMRT represses the expression of the gene
encoding an H3K27-speciﬁc demethylase KDM6B (JMJD3),
which is also a direct target of the retinoic acid receptor.
Retinoic acid induction leads to the release of SMRT from
the KDM6B gene promoter, and then KDM6B derepresses
neurogenicgenesinneuralstemcells.ThisﬁndinguncoveredJournal of Biomedicine and Biotechnology 7
a novel hierarchical relationship between the activities of
SMRT and HDM in maintaining the neural stem-cell state.
6. Conclusion
Many HDACs do not function by themselves but act as
a component in a multiprotein complex. This complex
formation appears to help each HDAC to exert its catalytic
activity more eﬀectively and/or speciﬁcally. As described
above, most HDAC-containing complexes are associated
with histone demethylases (HDMs), and the cooperative
action of these enzymatic activities enables the complex
to act on multiply modiﬁed histones at transcriptionally
repressive gene regions. Incorporating subtype components
gives rise to variations that allow these complexes to repress
a wide variety of target genes. Below, we summarize the
points raised in this paper.
(1) The two mammalian Sin3 complexes have distinct
functions. In embryonic development, mSin3A is
required during the preimplantation stage, whereas
mSin3B is required in late gestation. In particular,
mSin3B is essential for erythrocyte and granulocyte
diﬀerentiation.
(2) S. cerevisiae has two Sin3-containing complexes,
Rpd3L and Rpd3S. Rpd3L is required for transcrip-
tional repression at gene promoter regions, whereas
Rpd3S is located at transcribed regions and prevents
spurious transcription from incorrect transcription
start sites.
(3) The Drosophila KDM5 protein LID is associated with
the SIN3 complex. The LID-SIN3 complex functions
to repress the Notch-signaling pathway. Similarly, the
human KDM5A protein, RBP2, is required to repress
genes of the Notch-signaling pathway.
(4) Two types of MBD protein, MBD2 and MBD3,
are distinctively involved in the NuRD complex.
Mbd3/NuRD, but not Mbd2/NuRD, is essential for
mouse development. Another NuRD component,
MTA1/MTA2/MTA3, also contributes to produce
distinct complexes. NuRD complexes with each MTA
protein bind to speciﬁc promoter regions.
(5) Mouse embryonic stem cells contain a special-
ized NuRD-related complex, NODE. The stem-cell-
speciﬁc factors Nanog and Oct4 are associated with
the NODE complex, which represses several diﬀeren-
tiation marker genes.
(6) LSD1 (KDM1A) is associated with the NuRD com-
plex. There are three distinct LSD1-NuRD com-
plexes,LSD1/MTA1/NuRD,LSD1/MTA2/NuRD,and
LSD1/MTA3/NuRD. These three diﬀerent complexes
target distinct yet overlapping sets of genes.
(7) LSD1 is also associated with the CoREST complex.
Furthermore, all the CoREST complex components
are included in the CtBP-containing complex. Many
of these components are required for the repression
of the E-cadherin promoter.
(8) NCoR/SMRT is the transcriptional repression ma-
chinery for nuclear-receptor-mediated transcrip-
tion. NCoR has critical roles in neural diﬀerentiation
and hematopoiesis, whereas SMRT is required for
heart development. KDM4A is associated with the
NCoR complex, and its association is required for
ASCL2 gene repression. The NCoR complex also
bindsSMCX(KDM5C),andtheNCoR-SMCX-REST
complex functions in glial development.
The transcriptional repression machinery is highly elab-
orate, and we still lack a complete picture of the transcrip-
tional repression mechanisms. Future studies will continue
to uncover these complicated mechanisms.
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